In the majority of cases, Gushing's disease is the result of a small basoph
ilic corticotroph microadenoma with an average size of less than 5 mm. Tran
ssphenoidal microsurgery can cure patients with Gushing's disease; however,
selective removal of the lesion requires precise preoperative localization
. In this article, we present the pathological findings and clinical outcom
es of four patients who underwent inferior petrosal sinus sampling (IPSS) f
or ACTH, pituitary imaging and subsequent transsphenoidal surgery for the d
iagnosis and treatment of Gushing's disease. All patients fulfilled accepte
d biochemical criteria for the diagnosis of ACTH-dependent Gushing's syndro
me. Histological examination revealed a basophilic corticotroph adenoma in
two patients. In one other patient, only Crooke's hyalinization was found;
however, the patient achieved a complete clinical and biochemical remission
following a hemihypophysectomy based on IPSS findings. Thus, a microadenom
a was assumed or proven in three patients, of whom two were cured by surger
y alone. In the third patient, cortisol excess persisted following transsph
enoidal surgery because of a coexistent functioning adrenal adenoma. The fo
urth patient developed recurrent nodular corticotroph hyperplasia following
a 17-yr remission. The second transsphenoidal procedure failed to ameliora
te cortisol excess, necessitating a subsequent bilateral adrenalectomy. IPS
S accurately localized the site of the lesion in all four cases. Although m
agnetic resonance imaging (MRI) identified a distinct lesion in three cases
, two of these represented false positives (a cyst in one case and a prolac
tinoma in the other), whereas in only one did MRI correctly match the site
of the lesion. In each case, conflicting test results and/or difficult mana
gement decisions posed a challenge. Thus, successful resolution of disease
requires a multidisciplinary approach to validate clinical, biochemical, an
d radiographic data based on morphologic findings.